Tag Archives: risk sharing

Tufts R&D Outlook for 2011: Pain Mixed with Promise

By William Looney | Published: January 12, 2011
The Tufts Center for Drug Development issues its annual assessment of the state of R&D in Big Pharma, noting that industry faces a cumulative tide of challenges marked by a dramatic reversal in societal attitudes toward risk. Productivity gaps in the pipeline aside, perhaps the biggest problem is political — convincing stakeholders to strive for [...]
Posted in FDA, Gene therapy, R&D, Regulatory | Also tagged , , , , , | 1 Comment

Wins and Losses from Risk-Sharing Agreements

By William Looney | Published: November 17, 2010
Can you manage the external market impact? Risk-sharing agreements – where companies contract with reimbursement or assessment authorities to guarantee a new drug’s performance, often against specific outcomes measures, in return for access to patients – are among the latest innovations in managing health care costs. Use of the tool is standard in Australia, is [...]
Posted in Europe, Global, Regulatory, Strategy, healthcare, pricing | Also tagged , , , , , | Leave a comment